BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, February 13, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 3, 2014
View Archived Issues
Agilis and Intrexon collaborate on DNA-based therapeutics for Friedreich's ataxia
Read More
Oprozomib shows antitumor activity in phase I/II trials in patients with hematologic malignancies
Read More
TD-6450 demonstrates improved potency against genotype 1a-resistant mutants
Read More
Karyopharm presents results from phase I study of selinexor in hematological cancers
Read More
Meiji Seika Pharma begins phase II study of ME-1111
Read More
ASTX-727 demonstrates promising preclinical pharmacokinetic profile
Read More
ProNAi Therapeutics presents promising phase II data for PNT-2258
Read More
Japanese researchers prepare new agents for diabetes and other metabolic disorders
Read More
Janssen R&D Ireland patents novel agents for RSV infection
Read More
Novel neprilysin inhibitor prodrugs disclosed by Theravance
Read More
Georgia State University divulges novel agents for bacterial infections
Read More
Cerenis reports topline data for CER-001
Read More
Eisai launches Fycompa for partial-onset seizures in patients with epilepsy
Read More
IRM synthesizes novel EGFR inhibitors for cancer
Read More
NPS Pharmaceuticals begins registration study of teduglutide in pediatric patients
Read More
Horizon-labeled Vimovo now available in the U.S.
Read More
Incyte presents interim phase II results for INCB-039110 in patients with primary myelofibrosis
Read More
Marina Biotech and Mirna Therapeutics amend agreement for microRNA therapeutics
Read More
GlaxoSmithKline presents early clinical data for afuresertib
Read More
Sanofi presents phase II data for SAR-3419 and rituximab combination in B-cell lymphoma
Read More
Probiodrug transfers CDK9 inhibitor program to AstraZeneca
Read More
Salix Pharmaceuticals completes acquisition of Santarus
Read More
Enrollment open in phase IIa study of THR-18 in stroke patients treated with tPA
Read More
Sanofi expands access to data from clinical trials
Read More
